Greenwich LifeSciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $8.9M | $10.5M | $6.2M | $3.8M | $3.1M | $2.7M | $4.1M | $5.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $8.9M | $10.5M | $6.2M | — | — | — | $4.1M | — |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $876 | $1.8K | $2.7K |
| Total Assets | $8.9M | $10.5M | $6.2M | $3.8M | $3.1M | $2.8M | $4.1M | $5.8M |
| Liabilities | ||||||||
| Accounts Payable | $4.8M | $4.3M | $4.7M | $1.1M | $1.3M | $1.0M | $1.2M | $553.9K |
| Total Current Liabilities | $5.8M | $5.2M | $5.8M | $1.6M | $1.7M | $1.4M | $3.2M | $842.4K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $5.8M | $5.2M | $5.8M | $2.0M | $2.5M | $2.6M | $3.2M | $842.4K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-96.7M | $-92.8M | $-87.1M | $-77.6M | $-73.4M | $-69.4M | $-67.8M | $-58.1M |
| Total Stockholders' Equity | $3.1M | $5.3M | $353.2K | $2.2M | $604.3K | $200.5K | $908.6K | $5.0M |